With a robust background in venture capital, the fund manager has successfully executed over 50 deals, primarily in the technology and healthcare sectors across North America and Europe. Emphasizing a data-driven and thematic investment approach, they have cultivated a diverse portfolio that includes notable exits in biotechnology and software industries. Their strategic style focuses on operator-first principles, ensuring that each investment is backed by strong management teams. This blend of experience and targeted sector expertise positions them as a key player in the venture landscape.